Evolution of Clinical Care in COVID-Infected Solid Organ Transplant Recipients.
Curr Transplant Rep
; 9(3): 185-198, 2022.
Article
in English
| MEDLINE | ID: covidwho-1943554
ABSTRACT
Purpose of Review In this review, we aim to summarize the evolution of care for the solid organ transplant recipient (SOTR) with COVID-19 disease, based on the current published guidelines and our center's experience. Recent Findings:
Oral antiviral medications and monoclonal antibodies are now used with the goal to prevent severe disease. Immunomodulating drugs in addition to antivirals have been used in the treatment of severe COVID-19.Summary:
With the ongoing pandemic and unique challenges posed by the SOTR, understanding the risk and advancing management and treatment of COVID-19 infections are imperative to the successful care of a transplant recipient. There are many ongoing clinical trials being conducted in hopes of developing novel therapeutics towards COVID-19.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
Curr Transplant Rep
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS